1,1'-Carbonyldiimidazole → (R)-N-(5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxy-3-methylazetidine-1-carboxamide
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C@H:9]1[CH2:13][CH2:12][CH2:11][N:10]1[C:14]1[CH:19]=[CH:18][N:17]2[N:20]=[CH:21][C:22]([NH2:23])=[C:16]2[N:15]=1.C1N=CN([C:29](N2C=NC=C2)=[O:30])C=1.Cl.[CH3:37][C:38]1([OH:42])[CH2:41][NH:40][CH2:39]1.COC1CNC1.CCN(C(C)C)C(C)C>C(Cl)Cl>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C@H:9]1[CH2:13][CH2:12][CH2:11][N:10]1[C:14]1[CH:19]=[CH:18][N:17]2[N:20]=[CH:21][C:22]([NH:23][C:29]([N:40]3[CH2:41][C:38]([OH:42])([CH3:37])[CH2:39]3)=[O:30])=[C:16]2[N:15]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a DCM (0.8 mL) solution of (R)-5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (Example 8, Step A; 22 mg, 0.066 mmol) was added CDI (22 mg, 0.13 mmol) at ambient temperature in one portion. After stirring two hours, 3-methoxyazetidine 3-methylazetidin-3-ol hydrochloride (18 mg, 0.13 mmol) was added in one portion, followed by addition of DIEA (0.035 mL, 0.20 mmol). The reaction was stirred for 5 minutes before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 5 to 50% acetonitrile/water to yield the final product as a yellowish foamy powder (21 mg, 71% yield). MS (apci) m/z=445.2 (M+H).
Workup
- stirringThe reaction was stirred for 5 minutes before it
- concentrationwas concentrated
- customdirectly purified by reverse-phase column chromatography
- washeluting with 5 to 50% acetonitrile/water
Sources & evidence
- ORD record
- ord-62d3689c6474483f99388cd9c828e431
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08865698B2
Reaction notes
Loading…